Dahl Andrew M.
Dahl Andrew M., SVP, CTRL, reported an open-market or private sale at Edwards Lifesciences Corp involving 567.526600 shares for an estimated $48852.69. Reported holdings after the transaction were 15334.094800 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- May 29, 2026
- Filing date
- May 29, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 15,901.6214 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
EW price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001225208-26-005647 Common Stock
- Transaction date
- May 29, 2026 Filed May 29, 2026, 08:44 PM · 0d delay
- Shares
- 567.5266 sh $86.08 per share
- Estimated value
- -$48.8k Computed from shares × price
- Holdings after
- 15,334.0948 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 0
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
SVP, Corporate Controller
No footnotes recorded.
Original filing · 0001225208-26-0056470 other transactions
0 recent txs